GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (NEOE:CYBN) » Definitions » Long-Term Debt

Cybin (NEOE:CYBN) Long-Term Debt : C$0.00 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Long-Term Debt?

Cybin's Long-Term Debt for the quarter that ended in Sep. 2024 was C$0.00 Mil.

Cybin Long-Term Debt Historical Data

The historical data trend for Cybin's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Long-Term Debt Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
- - - - -

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cybin  (NEOE:CYBN) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Cybin Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Cybin's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (NEOE:CYBN) » Definitions » Long-Term Debt
Comparable Companies
TSX:FRX TSX:SVA TSX:ONC NEOE:MMED TSX:EPRX XCNQ:DTC TSXV:NGEN TSX:BCT XCNQ:MSET TSXV:ARCH OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CYBN:USA R7E:Germany
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Website
https://www.cybin.com
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
Executives
Gabriel Fahel Senior Officer
Gregory Joseph Cavers Senior Officer
Douglas Lee Drysdale Senior Officer
Paul Glavine 10% Security Holder, Director, Senior Officer
Eric So 10% Security Holder, Director, Senior Officer
Aaron Frank Bartlone Senior Officer